Analysts think LLY stock price could increase by 25%
May 03, 2025, 11:26 AM
-10.53%
What does LLY do
Eli Lilly & Co., headquartered in Indianapolis, employs 43,000 staff and develops various pharmaceutical products, including diabetes, oncology, immunology, and neuroscience therapies, alongside radiopharmaceuticals through its subsidiary POINT Biopharma. The company manufactures and distributes products in the U.S., Europe, and Asia.
28 analysts think LLY stock price will increase by 24.96%. The current median analyst target is $1030.20 compared to a current stock price of $824.40. The lowest analysts target is $808.00 and the highest analyst target is $1249.50.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
